Search results

Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
Non-invasive Coronary Functional Tests in ANOCA
Author(s): Nello Cambise , Angelo Giuseppe Marino , Fabio De Benedetto , et al Added: 3 months ago

Imaging & Diagnostics

Prevention & Chronic Conditions
Left Main Disease: The Last Frontier for Medical Therapy in Stable CAD?
Author(s): Armin Arbab-Zadeh , Michelle Graham , Hector M Garcia-Garcia , et al Added: 8 months ago

Intervention

Prevention & Chronic Conditions
Updates on Chronic Coronary Syndrome
Author(s): Filippo Gurgoglione , Giampaolo Niccoli Added: 1 year ago

Prevention & Chronic Conditions

CV Disease in Special Populations
EMPA-KIDNEY: Empagliflozin in Patients with Chronic Kidney Disease
Author(s): William Herrington Added: 1 year ago
Long-term cardio-renal outcomes investigating empagliflozin (Boehringer Ingelheim) on kidney disease progression (KDP) or cardiovascular death in patients with pre-existing chronic kidney disease.In this short interview, Prof William Herrington (Nuffield Department of Population Health, University of Oxford, Oxford, UK) discusses the findings from EMPA-KIDNEY (NCT03594110).EMPA-KIDNEY is an… View more

Prevention & Chronic Conditions

Cardiovascular Kidney Metabolic
30th Annual Meeting of the ISCP
Author(s): Diego Manuel de la Eranueva , Ignacio Quevedo , Adela Castro Garcia , et al Added: 1 month ago

Prevention & Chronic Conditions

Heart Failure
Antithrombotics in stable CAD and AF
Author(s): Massimo Grimaldi , Bianca Rocca Added: 2 months ago

Prevention & Chronic Conditions

Anticoagulation
30th Annual Meeting of the ISCP
Author(s): Inés Martínez-Salgado , Manuel Sánchez , Diego De la Eranueva Calvo , et al Added: 1 month ago

Prevention & Chronic Conditions

Heart Failure
Yield and Characterisation of CFT in ANOCA
Author(s): Johanna McChord , Astrid Hubert , Udo Sechtem , et al Added: 1 year ago

Prevention & Chronic Conditions
ACC 25: The EKSTROM Trial
Author(s): Matthew J Budoff Added: 1 year ago
ACC 2025 - Outcomes from colchicine in patients with stable coronary artery disease (CAD) shows significant plaque volume progression compared to placebo at one year.Dr Matthew Budoff (UCLA Medical Centre, Los Angeles, US) joins us onsite at ACC 2025 to discuss findings from the randomized, placebo-controlled, investigator-initiated EKSTROM trial (NCT06342609; Lundquist Institute for Biomedical… View more

Intervention
ACC 25 Late-Breaking Discussion: The FRESH-UP Trial
Author(s): Harriette Van Spall , Roland RJ van Kimmenade Added: 1 year ago
ACC 25 - FRESH-UP shows liberal fluid intake did not result in a significant difference in health status compared to fluid restriction of 1500ml per day, but did result in a lower perceived thirst distress.Dr Harriette Van Spall (McMaster University, CA) sits down with Dr Roland Van Kimmenade (Radboud University Medical Center, Nijmegen, NL) to discuss the findings from the multi-center,… View more

Heart Failure